HALOZYME THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 12452000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2017-03-31) |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ec82e1f8-b7f1-42b9-8fd6-305a2a9bdea9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-17-000030Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/accounts-receivable/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ec82e1f8-b7f1-42b9-8fd6-305a2a9bdea9
History
- no predecessors — first report